Video LibraryHighlights from ESC Congress 2021: Part Two
In this second video from the ESC 2021, Professor Cannon and Professor Nicholls discuss late-breaking results from the HUGYENs trial on evolcoumab, as well as the ESC prevention guidelines and the impact of the NHS approval of Inclisiran in improving patient care.
Christopher Cannon, MD & Professor Stephen Nicholls, MBBS, Ph.D., FRACP, FACC, FESC, FAHA, FCSANZ, FAHMS
First published: September 15, 2021
In this second video from the ESC 2021, Professor Cannon and Professor Nicholls discuss late-breaking results from the HUGYENs trial on evolcoumab, as well as the ESC prevention guidelines and the impact of the NHS approval of Inclisiran in improving patient care.
Christopher Cannon, MD & Professor Stephen Nicholls, MBBS, Ph.D., FRACP, FACC, FESC, FAHA, FCSANZ, FAHMS
First published: September 15, 2021